Medicinova

MediciNova, Inc. develops small‑molecule therapies for serious illnesses, including MN‑166 (neuroprotection) in advanced trials for MS & ALS, MN‑001 (fibrosis) & MN‑029 (cancer), targeting high‑unmet markets with strong partnership backing.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Hospitals and Health Care
Industry: Medical Practices

Employees: 13
HQ: La Jolla

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
MNOV	Medicinova Cap: 0.1B	EQUITY	NMS	USD	US58468P2065	Active	📈